Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FT2EJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,604
Award facts
- Contract value 100% obligated
- $13,603.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (quantity: 30 units) under a firm fixed-price contract valued at $13,603.58. The delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a non-competitive award to support federal pharmaceutical procurement. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. As a critical vendor within the federal medical supply chain, AmerisourceBergen maintains an extensive portfolio of pharmaceutical products and medical supplies supporting Defense Health Agency and other government healthcare systems. The company's delivery orders through the DLA Troop Support Medical contract consistently demonstrate competitive capability across firm fixed-price arrangements, ranging from small-value transactions to substantial orders, positioning it as a key provider of brand-name medications, generic drugs, and specialized healthcare commodities to military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FT2EJ?
SPE2DR26FT2EJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FT2EJ worth?
The government has obligated $13,604 on SPE2DR26FT2EJ.
Is contract SPE2DR26FT2EJ an order under another contract?
Yes. SPE2DR26FT2EJ is a delivery order under SPE2DR25D3109, an indefinite delivery contract.
Was contract SPE2DR26FT2EJ competed?
The extent of competition for SPE2DR26FT2EJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award